Viewing Study NCT05021120


Ignite Creation Date: 2025-12-25 @ 4:06 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT05021120
Status: COMPLETED
Last Update Posted: 2025-12-04
First Post: 2021-08-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK127 in Combination With AK104 in Advanced and Metastatic Solid Tumours
Sponsor: Akesobio Australia Pty Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module